Congenital Sucrase-Isomaltase Deficiency Fund Grant
Healthwell Foundation
Funding Amount
Up to US $10,000
Deadline
Rolling / Open
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Well bases eligibility on an individual’s medical, financial and insurance situation.
- Well assists individuals with incomes up to 300-500% of the Federal Poverty Level.
Other requirements
- Do I Qualify?Health.
- To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:You are being treated for Congenital Sucrase-Isomaltase Deficiency.
- We can only assist with medications that have been prescribed to treat the disease/covered diagnosis.
- You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature.
Not eligible / not funded
- Not eligible: The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.
Overview
The Congenital Sucrase-Isomaltase Deficiency Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients suffering from this genetic disorder. By providing assistance with prescription drugs and treatment costs, the fund ensures that vital medications are accessible, allowing patients to manage their condition effectively. In 2024, the Foundation is expected to award over $1.2 billion in grants, showcasing its commitment to enhancing healthcare access for those in need.
Note: If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available.
In 2025, we awarded more than $1.1 billion in grants through our Disease Funds, and since 2004 we have helped more than 1,390,000 patients afford essential treatments and medications. HealthWell is recognized as one of America’s most efficient charities — 100 percent of every dollar donated goes directly to patient grants and services.
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment and management of congenital sucrase-isomaltase deficiency.
Grant Utilization
HealthWell estimates that patients use an average of $3,000 during their 12-month grant period for this disease area.
Eligibility
Do I Qualify?HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:You are being treated for Congenital Sucrase-Isomaltase Deficiency.We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.You have insurance and it covers your medication.To qualify for copayment assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. Please note that in order to qualify for premium assistance through this fund, you must have Medicare Part B. Your income falls within our guidelines.HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level.Household Income Limit 500% of the Federal Poverty Level(adjusted for household size and high cost of living areas)The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.You are receiving treatment in the United States.Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
Ineligibility
The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.
Focus Areas & Funding Uses
Fields of Work
- Hardship
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Peyronie's Disease Fund Grant
Healthwell Foundation
Amount
Up to US $5,600
Deadline
Rolling / Open
ANCA-Assoc Vasculitis and Granulomatosis with Polyangiitis Fund Grant
Healthwell Foundation
Amount
Up to US $6,000
Deadline
Rolling / Open
IgA Nephropathy Fund Grant
Healthwell Foundation
Amount
Up to US $9,000
Deadline
Rolling / Open
Emergency/Medical Workers Behavioral Health Fund Grant
Healthwell Foundation
Amount
Up to US $2,000
Deadline
Rolling / Open
Dupuytren’s Disease Fund Grant
Healthwell Foundation
Amount
Up to US $3,500
Deadline
Rolling / Open
Metabolic Dysfunction-Associated Steatohepatitis Fund Grant
Healthwell Foundation
Amount
Up to US $8,000
Deadline
Rolling / Open
Ready to apply for Congenital Sucrase-Isomaltase Deficiency Fund Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Congenital Sucrase-Isomaltase Deficiency Fund Grant. Now let's win it.